The assessment of non-culprit stenoses is an important issue in ACS. Adenosine administration is currently required for functional evaluation of stenosis severity using the fractional flow reserve (FFR). An alternative adenosine-independent index of coronary stenosis, the instantaneous wave-free ratio (iFR), was recently introduced. Aim of the present study was to evaluate the trans-stenotic instantaneous wave-free pressure gradient (iFG), the instantaneous wave-free ratio (iFR) and the fractional flow reserve (FFR) in ACS patients. Methods: Intracoronary diastolic pressure was measured proximal and distal to the stenosis during the wave-free period with a pressure wire (Certus, St. Jude, USA) at baseline and upon iv adenosine administration (140 ug/kg/min). The data were acquired with a PowerLab (AD Instruments, USA) and analyzed with a LabChart 7. Results: A total of 71 stenoses were evaluated in the present study. iFR showed a correlation with FFR (rϭ0.61, pϽ0.001), while a proportional error was documented with the Bland-Altman analysis. At multivariate analysis, the localization of the evaluated stenosis within the coronary tree influenced the correlation of iFR with FFR (pϭ0.03). ROC analysis showed a promising diagnostic efficiency for detection of significant coronary stenosis with iFR (AUCϭ0.936; pϽ0.001) or iFG (AUCϭ0.944; pϽ0.001). Interestingly, iFR showed a sensitivity of 88.2% and a specificity of 75.9%, when the diagnostic threshold was set at 0.93. Similarly, iFG showed a sensitivity of 94.1% and a specificity of 79.6%, when the diagnostic threshold was set at 5.55 mmHg.
Conclusions:
Endothelium-dependent vasomotion is heterogenous within the conduit system. Despite similar degrees of plaque burden, the LMCA and its most adjacent epicardial segment display greater degrees of vascular stiffness than the remainder of the more distal epicardial tree. These observations may provide mechanistic insights into the focal nature of coronary plaque progression and stability in vivo.
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Outcomes of Deferred FFR-Negative Stenoses: Real World Experience in a Community-Based Cardiac Referral Center
Michael Ho 1 , Michael Ho 1 , Shuwen Chen 1 1 Kaiser Permanente Medical Center, Santa Clara, CA Background: Fractional flow reserve (FFR) guided percutaneous coronary intervention (PCI) has been validated in the FAME trial, which demonstrated a statistically significant reduction in the composite of death or myocardial infarction compared to an angiographic-guided approach. At two years of follow-up, 3.2% of patients who had deferral of a FFR negative stenosis (Ͼ 0.80) returned for revascularization of the deferred lesion. Only 0.2% of the deferred lesions resulted in a late myocardial infarction (MI). We sought to evaluate the outcomes of FFR-deferred lesions in a community-based cardiac referral center. Methods: A retrospective analysis was conducted of the FFR cases performed at Kaiser Permanente Medical Center in Santa Clara, CA over a two-year period. Outcomes of the patients who had deferral of FFR negative lesions were assessed out to two years. Results: 5,558 patients underwent diagnostic coronary catheterization from 2010-2011. FFR was performed on 219 patients with a total of 224 intermediate coronary lesions undergoing hemodynamic FFR assessment. 144 stenoses (64.3% of total FFRs) were found to be Ͼ0.80 and PCI was deferred in these 140 patients. From this cohort, 38 lesions from a total of 32 patients returned for subsequent coronary angiography. Reasons for repeat angiography included post-cardiac transplant surveillance, stable angina, unstable angina, or MI. Of the 32 patients, 10 patients (7.1% of total deferred FFR patients) underwent revascularization of the originally deferred lesion, with 8 undergoing PCI and 2 undergoing CABG surgery. Average length from deferral to subsequent revascularization was 257 days. None of the originally deferred lesions resulted in a late MI or in-hospital death out to two years of follow-up. Conclusions: Fractional flow reserve assessment has been increasingly adopted at our cardiac referral center and accounted for 3.9% of patients that underwent coronary angiography over the initial two years of adoption. FFR-guided therapy yielded outcomes that were comparable to that seen in the FAME study, with 7.1% of deferred lesions requiring revascularization and no deferred stenosis resulting in a subsequent MI or in-hospital death. Background: Fractional flow reserve (FFR) is helpful to evaluate physiological severity of coronary stenosis. Pharmacologic stimulus such as adenosine triphosphate (ATP) is needed to obtain maximal hyperemia. Nicorandil, which is an ATP sensitive potassium channel opener, recognized as vasodilator of epicardial and resistance vessels. However, safety and feasibility of FFR with nicorandil has not been fully evaluated yet. Methods: This study consisted of 32 patients with 39 de novo lesions which underwent FFR measurements with both ATP and nicorandil stimulus. All patients first received intravenous ATP infusion at a rate of 150 g/kg/min and measured FFR-ATP. After the recovery to baseline was verified, patients received intracoronary nicorandil (1.5 mg to left coronary artery or 1.0mg to right coronary artery) to obtain maximal hyperemia and measured FFR-Nico. Results: A total of 18 left anterior descending, 10 left circumflex, and 11 right coronary arteries were evaluated. Mean diameter stenosis by QCA was 58.8Ϯ14.8%. A strong correlation was observed between FFR-ATP and FFR-Nico (rϭ0.960, pϽ0.0001). The agreement between the 2 sets of measurements was also high, with a mean difference of 0.0003 and 2SD of 0.0696. The mean aortic pressure drop during pharmacological stimulus was significantly larger in ATP than in niocrandil (10.6Ϯ9.5 mmHg vs. 5.4Ϯ7.2 mmHg, pϭ0.01).
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